Latest News

 

Board Announcement – Appointment of new CEO

HORSHAM, UK – 01 SEPTEMBER 2022 – The Board of Veryan Holdings Ltd announces that, following 11 years of service, including 8 years as COO and 3 years as CEO, Nick Yeo has decided to leave Veryan to pursue new professional and personal goals.

 

EVT Article- Sept 2020

The Role of the BioMimics 3D® Stent in FemPop Intervention: A Look Ahead at Use in the United States

 

BioMimics 3D US launch

Veryan Medical (Horsham, UK) today announced that it has launched the innovative BioMimics 3D Vascular Stent System in the US. The BioMimics 3D self-expanding, nitinol stent features a highly-differentiated, helical centre-line design that has achieved excellent clinical outcomes in clinical trials, including a pivotal study with 3-year follow-up.

Featured story

01 September 2022

Board Announcement –

Appointment of new CEO

HORSHAM, UK – 01 SEPTEMBER 2022 – The Board of Veryan Holdings Ltd announces that, following 11 years of service, including 8 years as COO and 3 years as CEO, Nick Yeo has decided to leave Veryan to pursue new professional and personal goals.

BioMimics-3D® Vascular Stent System

To accomplish great things we need to act but also to dream, not only to plan but also to believe.

Technical information

Technical Information for the BioMimics 3D Vascular Stent System.

Clinical evidence

The MIMICS Clinical Program: An evolving database of the safety and effectiveness of the BioMimics-3D Vascular Stent System.